Rhythm Pharmaceuticals Stock (NASDAQ: RYTM)

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock, Unusual Options

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc. - Common Stock

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Comments

Rhythm Pharmaceuticals Unusual Options